NLRP3 and metabolic dysfunction-associated steatotic liver disease: Moreover, novel-miR-7 genetic inhibition significantly restored NLRP3 inflammasome-dependent microvascular endothelial hyperpermeability induced by NAFLD hepatic sEVs both in vivo and in vitro.